Skip to main content

Market Overview

Recap: BioLife Solutions Q1 Earnings


Shares of BioLife Solutions (NASDAQ:BLFS) increase in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share decreased 83.33% year over year to $0.01, which beat the estimate of ($0.04).

Revenue of $16,847,000 higher by 38.52% year over year, which beat the estimate of $16,050,000.


BioLife Raises FY21 Sales Guidance To $106M-$115M vs $105.7M Estimate

How To Listen To The Conference Call

Date: May 13, 2021

Time: 04:30 PM

ET Webcast URL:


52-week high: $47.97

52-week low: $13.76

Price action over last quarter: down 29.66%

Company Description

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.


Related Articles (BLFS)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings